FUTURE HEALTH
NUROFLUX
Medical device for continuous monitoring of brain activity and blood flow in stroke patients
STARTUP
There is currently no mechanism available for objective , continuous monitoring of brain activity and blood flow in stroke patients . However , these are key indicators of patient deterioration and treatment outcome . Standard of care relies on intensive and subjective nursing assessments which are disruptive to patients and present high operational burdens to hospitals .
Nuroflux has developed a medical device for the safe and passive monitoring of brain activity and blood flow in patients suffering from stroke . Real-time detection of abnormalities will provide clinical staff with early and actionable insights , improving patient outcomes .
Nuroflux has validated the technology against the gold standard for short-term brain monitoring , demonstrated safety and acceptability in stroke patients , and secured funding to initiate a clinical efficacy study in a cohort of stroke patients to acquire sensitivity and specificity measures .
> Invention of a proprietary methodology for the continuous monitoring of cerebral blood flow ( currently the subject of a National Phase IP filing with a clear international preliminary report on patentability ).
> Validation of the core technology against the current gold standard of short-term cerebral blood flow monitoring ( transcranial Doppler ultrasound ) in a cohort of healthy volunteers .
> Demonstration of safety , feasibility and tolerability in a cohort of ischaemic stroke patients .
> Received over half a million dollars in funding from equity investment , awards and grants .
• 49